THERMO FISHER SCIENTIFIC INC. FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $44.6B |
| Gross margin | — not reported |
| Operating income | $7.7B |
| Net income | $6.7B |
| Diluted EPS | $17.74 |
| Cash & equivalents | $9.9B |
| Total assets | $110.3B |
| Long-term debt | $39.2B |
Key takeaway
Thermo Fisher reported $44.56 billion in revenue and $6.70 billion in net income for fiscal 2025, with diluted EPS of $17.74.
🔒 4 more takeaways in the full analysis
Beneath the surface
Cash and equivalents of $9.85 billion versus total debt near $39.38-39.46 billion implies a substantial net debt position of roughly $29.5-29.6 billion, a leverage level not obvious from the headline cash and debt figures alone.
🔒 3 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for TMO.
Read the full analysis free Free account · 5 full analyses included · no card required